Beleave - Everything You've Ever Wanted to Know
March 26 2018 - 1:22PM
InvestorsHub NewsWire
Beleave - Everything
You've Ever Wanted to Know
TORONTO, Canada -- March 26, 2018-- InvestorsHub NewsWire
-- Beleave Inc. ("Beleave" or the
"Company") (CSE: BE; OTCQX: BLEVF) is pleased to, on
the back of yesterdays positive Senate vote in favour of Bill C-45,
provide a video overview of each of the company's current
initiatives.
"Yesterday's Bill C-45 debate and passing marks another significant
step towards the legalization of cannabis in Canada,"
Commented Beleave CEO Andrew Wnek, "We have the utmost respect
for the process and with good debate we are confident that the
right decision has been made. We are proud to part of this
new change and to be global leaders in this industry. In
addition, we have launched our YouTube channel where periodically
we will post updates on company progress. The goal of the channel
is to introduce the many faces working hard at maintaining the
Beleave standard in their field of expertise."
The
following videos have been published for the launch of
the "Beleave Inc." YouTube
Channel. Please click the link to view.
Beleave
- Dr. Peter Chen & Dr. Michael Rogers speak
about Food and Drug Delivery
Beleave
CEO Andrew Wnek speaks about Beleave's progress and
highlights of the year.
Beleave
CFO Bojan Krasic speaks about Beleave's financial
position and cash flows.
Beleave
CSO Dr. Roger Ferreira speaks about cannabis research and
innovation.
Beleave
COO Bill Panagiotakopoulos speaks about Beleave's hybrid
greenhouse expansion.
Beleave
- Dr. Ming Miao Marshall speaks about Patient-Pending
Extract Technology
Beleave
- Dr. Mohit Bhandari speaks about Clinical
Research
Beleave - Dr. Leslie
Campbell speaks about Genetics and Breading
Project
About
Beleave
Beleave Inc. is a biotech company and Beleave's wholly-owned
subsidiary Beleave Kannabis Corp. (formerly First Access Medical
Inc.) is a licensed producer pursuant to the ACMPR. Beleave's
purpose-built facility is located in Hamilton,
Ontario.
On Behalf of the Board of
Directors
Andrew
Wnek – Chief Executive Officer
For further
information please contact:
Sebastian de Kloet
Phone: (905) 979 - 5173
Email: sebastian@beleave.com
beleave.com
Forward-Looking
Statements
This
news release contains "forward-looking information" within the
meaning of applicable securities law ("forward-looking
statements"). The use of any of the words "plan", "anticipate",
"continue", "estimate", "expect", "may", "will", "project",
"should", "believe" and other similar words, or statements that
certain events or conditions "may" or "will" occur are intended to
identify forward-looking information. These statements are only
predictions. Although the Company believes that the expectations
and assumptions on which the forward-looking information is based
are reasonable, undue reliance should not be placed on the
forward-looking information because the Company can give no
assurance that they will prove to be correct. These risks and
uncertainties include, but are not limited to, the Company's
ability to satisfy the conditions associated with its cultivation
license, the Company's ability to obtain a sales license and the
related timing considerations, the availability of further
financing, consumer interest in its products, competition,
regulation, operational and technological risks, and anticipated
and unanticipated costs and delays. Since forward-looking
information addresses future events and conditions, by its very
nature it involves inherent risks and uncertainties. This
information speak only as of the date of this news release. Actual
results could differ materially from those currently anticipated
due to a number of factors and risks including various risk factors
discussed in the Company's disclosure documents, which can be found
under the Company's profile on www.sedar.com .
SOURCE
Beleave Inc.
Beleave (CSE:BE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Beleave (CSE:BE)
Historical Stock Chart
From Dec 2023 to Dec 2024
